N@N

Solta Medical Inc (NASDAQ:SLTM), Down By 6.35% ($0.19) From $2.990 After BUYINS.NET Report Predicted Weakness After Earnings

October 31, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Monday, October 29th 2012 stating that Solta Medical Inc (NASDAQ:SLTM) was expected to be Down After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=sltm&id=322979

At the time this story was written, Solta Medical Inc (NASDAQ:SLTM) is Down By 6.35% ($0.19) From $2.990 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

Solta Medical Inc (NASDAQ:SLTM) - Solta Medical, Inc. designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications. Its products include Thermage NXT and CPT systems that provide non-invasive treatment options for skin tightening and contouring, body shaping, and enhancement in the appearance of cellulite; Fraxel re:fine and Fraxel re:store systems, which offer treatments for skin conditions, such as fine lines and pigmentation; and Fraxel re:pair system for dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, as well as for rhytides, pigmentation, and vascular dyschromia. The companys Fraxel re:store system also offers treatments for acne and surgical scars, deeper lines and wrinkles, and actinic keratoses. Its systems consist of one or more hand pieces, a console that incorporates a graphical user interface, an energy source and electronics, and a disposable treatment tip. The companys customers include dermatologists, plastic surgeons, general and family practitioners, gynecologists, and ophthalmologists. Solta Medical markets its systems and treatment tips through direct sales force and a network of distributors in the United States and internationally. The company was formerly known as Thermage, Inc. and changed its name to Solta Medical, Inc. in December 2008. The company was founded in 1995 and is headquartered in Hayward, California..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Solta Medical Inc (NASDAQ:SLTM) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources

---